FENOFIBRATE
Marketedupdated 2mo agoby Orit Laboratories LLC
Approvedcommunity read0 votes
indications
investigational
Hyperlipidemia
all catalysts(19)
approval · 19
Nov 30, 2004
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Oct 21, 2005
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Jun 3, 2008
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Mar 1, 2012
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Dec 19, 2012
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Oct 18, 2013
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Sep 4, 2014
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Aug 31, 2015
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Nov 9, 2016
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Nov 29, 2016
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Sep 11, 2017
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
May 18, 2018
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that